"10.1371_journal.pone.0149405","plos one","2016-02-26T00:00:00Z","Wendy W J de Leng; Christa G Gadellaa-van Hooijdonk; Fran√ßoise A S Barendregt-Smouter; Marco J Koudijs; Ies Nijman; John W J Hinrichs; Edwin Cuppen; Stef van Lieshout; Robert D Loberg; Maja de Jonge; Emile E Voest; Roel A de Weger; Neeltje Steeghs; Marlies H G Langenberg; Stefan Sleijfer; Stefan M Willems; Martijn P Lolkema","Department of Pathology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands; Department of Medical Genetics, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; Medical Sciences, Amgen Inc., Thousand Oaks, CA, 91320‚Ä1799, United States of America; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, 3075 EA Rotterdam, The Netherlands","Conceived and designed the experiments: WL CG FS EC IN EV RW SW MPL. Analyzed the data: WL CG FS JH MK SL IN. Contributed reagents/materials/analysis tools: RL NS MJ MHL SS. Wrote the paper: WL CG FS MPL.","RL is employed by and owns stock in Amgen Inc. The other authors declare no conflicts of interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","02","Wendy W J de Leng","WWJDL",17,TRUE,9,NA,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
